Article
Suppression of MMP-9 by doxycycline in brain arteriovenous malformations
24 Jan 2005
Abstract excerpt
BACKGROUND: The primary aim of this study is to demonstrate the feasibility of utilizing doxycycline to suppress matrix metalloproteinase-9 (MMP-9) in brain arteriovenous malformations (AVMs). METHODS: Ex-vivo treatment of AVM tissues: Intact AVM tissues were treated with doxycycline for 48 hours. Active and total MMP-9 in the medium were measured. Pilot trial: AVM patients received either doxycycline (100 mg) or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
